Mineralys Therapeutics (MLYS) Current Assets (2022 - 2026)
Quarterly results put Current Assets at $652.5 million for Q1 2026, up 84.05% from a year ago — trailing twelve months through Mar 2026 was $652.5 million (up 84.05% YoY), and the annual figure for FY2025 was $661.4 million, up 222.08%.
Mineralys Therapeutics has reported Current Assets over the past 5 years, most recently at $652.5 million for Q1 2026.
- Current Assets reached $652.5 million in Q1 2026 per MLYS's latest filing, down from $661.4 million in the prior quarter.
- Across five years, Current Assets topped out at $661.4 million in Q4 2025 and bottomed at $112.8 million in Q4 2022.
- Median Current Assets over the past 5 years was $296.6 million (2023), compared with a mean of $351.0 million.
- The largest annual shift saw Current Assets decreased 17.56% in 2024 before it skyrocketed 222.08% in 2025.
- Over 5 years, Current Assets stood at $112.8 million in 2022, then soared by 120.81% to $249.1 million in 2023, then decreased by 17.56% to $205.4 million in 2024, then surged by 222.08% to $661.4 million in 2025, then dropped by 1.35% to $652.5 million in 2026.
- Business Quant data shows Current Assets for MLYS at $652.5 million in Q1 2026, $661.4 million in Q4 2025, and $599.8 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 10.37 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | 37.31 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 1.25 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | 73.04 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | 3.59 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 11.73 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 18.21 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 4.22 Bn |
| 10 | Mineralys Therapeutics | 2.50 Bn | 2.50 Bn | - | 652.47 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 652.47 Mn |
| Dec 31, 2025 | 661.39 Mn |
| Sep 30, 2025 | 599.80 Mn |
| Jun 30, 2025 | 335.27 Mn |
| Mar 31, 2025 | 354.51 Mn |
| Dec 31, 2024 | 205.35 Mn |
| Sep 30, 2024 | 267.73 Mn |
| Jun 30, 2024 | 318.00 Mn |
| Mar 31, 2024 | 346.82 Mn |
| Dec 31, 2023 | 249.10 Mn |
| Sep 30, 2023 | 265.38 Mn |
| Jun 30, 2023 | 269.49 Mn |
| Mar 31, 2023 | 275.27 Mn |
| Dec 31, 2022 | 112.81 Mn |